ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,848, issued on March 4, was assigned to Avicenna Biosciences Inc. (Durham, N.C.).
"Azaindole rock inhibitors" was invented by Thomas Maxwell Kaiser (Charleston, S.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein."
The patent was filed on March 19, 2024, under Application No. 18/610,051.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12240848&O...